SearcharxivSearch

arXiv subjects

Christoph Gorgulla

Publications and source records attributed to Christoph Gorgulla.

6 recordsLinked to original sources

Faster Algorithmic Quantum and Classical Simulations by Corrected Product Formulas

Hamiltonian simulation using product formulas is arguably the most straightforward and practical approach for algorithmic simulation of a quantum system's dynamics on a quantum computer. Here we present corrected product formulas (CPFs), a variation of product formulas achieved by injecting auxiliary terms called correctors into standard product formulas. We establish several correctors that improve the accuracy of standard product formulas by orders of magnitude when simulating Hamiltonians comprised of two exactly simulatable partitions, a common structure of lattice Hamiltonians. Importantly, injecting these correctors increases the overall simulation cost by only a small additive or multiplicative factor. We show that correctors are particularly advantageous for perturbed systems, where one partition has a relatively small norm compared to the other, as they allow the small norm to be utilized as an additional parameter for controlling the simulation error. We demonstrate the performance of CPFs by numerical simulations for several lattice Hamiltonians. Numerical results show that our theoretical error bounds for CPFs match or outperform the empirical error scaling of standard product formulas for these systems. We also demonstrate improvements offered by CPFs by implementing small-size systems on actual quantum hardware, as well as on noisy and noiseless quantum simulators. CPFs could be a valuable algorithmic tool for early fault-tolerant quantum computers with limited computing resources. As for standard product formulas, CPFs could also be used for simulations on a classical computer.

quant-ph

The generative quantum eigensolver (GQE) and its application for ground state search

We introduce the generative quantum eigensolver (GQE), a new quantum computational framework that operates outside the variational quantum algorithm paradigm by applying classical generative models to quantum simulation. The GQE algorithm optimizes a classical generative model to produce quantum circuits with desired properties. Here, we develop a transformer-based implementation, which we name the generative pre-trained transformer-based (GPT) quantum eigensolver (GPT-QE). We show a proof-of-concept of training and pretraining of GPT-QE applied to electronic structure Hamiltonians, and demonstrate its ability illustrated by surpassing coupled cluster singles and doubles (CCSD) for the strong bond dissociation of the nitrogen molecule and approaching chemical accuracy. We also demonstrate the method on real quantum hardware.

quant-ph

Chemically Motivated Simulation Problems are Efficiently Solvable by a Quantum Computer

Simulating chemical systems is highly sought after and computationally challenging, as the number of degrees of freedom increases exponentially with the size of the system. Quantum computers have been proposed as a computational means to overcome this bottleneck , thanks to their capability of representing this amount of information efficiently. Most efforts so far have been centered around determining the ground states of chemical systems. However, hardness results and the lack of theoretical guarantees for efficient heuristics for initial-state generation shed doubt on the feasibility. Here, we propose a heuristically guided approach that is based on inherently efficient routines to solve chemical simulation problems, requiring quantum circuits of size scaling polynomially in relevant system parameters. If a set of assumptions can be satisfied, our approach finds good initial states for dynamics simulation by assembling them in a scattering tree. In particular, we investigate a scattering-based state preparation approach within the context of mergo-association. We discuss a variety of quantities of chemical interest that can be measured after the quantum simulation of a process, e.g., a reaction, following its corresponding initial state preparation.

quant-ph

Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS

The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engagement with KRAS. ISM061-018-2 was identified as a broad-spectrum KRAS inhibitor, exhibiting a binding affinity to KRAS-G12D at $1.4 μM$. Concurrently, ISM061-22 exhibited specific mutant selectivity, displaying heightened activity against KRAS G12R and Q61H mutants. To our knowledge, this work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits, showcasing the practical potential of quantum-assisted drug discovery to produce viable therapeutics. Moreover, our findings reveal that the efficacy of distribution learning correlates with the number of qubits utilized, underlining the scalability potential of quantum computing resources. Overall, we anticipate our results to be a stepping stone towards developing more advanced quantum generative models in drug discovery.

quant-ph

Industry applications of neutral-atom quantum computing solving independent set problems

Architectures for quantum computing based on neutral atoms have risen to prominence as candidates for both near and long-term applications. These devices are particularly well suited to solve independent set problems, as the combinatorial constraints can be naturally encoded in the low-energy Hilbert space due to the Rydberg blockade mechanism. Here, we approach this connection with a focus on a particular device architecture and explore the ubiquity and utility of independent set problems by providing examples of real-world applications. After a pedagogical introduction of basic graph theory concepts of relevance, we briefly discuss how to encode independent set problems in Rydberg Hamiltonians. We then outline the major classes of independent set problems and include associated example applications with industry and social relevance. We determine a wide range of sectors that could benefit from efficient solutions of independent set problems -- from telecommunications and logistics to finance and strategic planning -- and display some general strategies for efficient problem encoding and implementation on neutral-atom platforms.

quant-ph

Recent Developments in Structure-Based Virtual Screening Approaches

Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year. To solve these problems, new and innovate technologies are needed that make the drug discovery process of small-molecules more time and cost-efficient, and which allow to target previously undruggable target classes such as protein-protein interactions. Structure-based virtual screenings have become a leading contender in this context. In this review, we give an introduction to the foundations of structure-based virtual screenings, and survey their progress in the past few years. We outline key principles, recent success stories, new methods, available software, and promising future research directions. Virtual screenings have an enormous potential for the development of new small-molecule drugs, and are already starting to transform early-stage drug discovery.

q-bio.BM